glp 1 and atrial fibrillation For patients with obesity fibrillation, GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested. https://www.medpagetoday.com/cardiology/arrhythmias/120327 Association of Glucagon-Like Peptide-1 Receptor

Due to their preclinical testing and lack of comparison with other dual receptor agonists such as tirzepatide, further studies are needed to determine whether the effects of these unimolecular compounds are superior to those of clinically tested drugs

found that exendin-4 increased the membrane protein level of the AMPA receptor GluR1 subunit and postsynaptic density protein-95, which were the critical mechanisms of long-term potentiation (LTP) as well as the formation of learning and memory (178)

Amgens approach is based on research showing that mice that lack GIP, as well as people with mutations in this receptor, have lower body weight

The bottom line: There may be hope in these bottles

Lastly, the thematic analysis was carried out, to synthesize and interpret all the data that appeared from the included publications

B., Diplock A